Quick Answer
Sonoma Pharmaceuticals, Inc. reported Shares Outstanding of 1.63 million shares for fiscal year 2025.
Sonoma Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.63M | +54.4% |
| 2024 | 1.06M | +35.6% |
| 2024 | 780,371 | -84.2% |
| 2023 | 4.93M | +59.1% |
| 2022 | 3.10M | +48.2% |
| 2021 | 2.09M | +17.7% |
| 2020 | 1.78M | +33.8% |
| 2019 | 1.33M | +1.0% |
| 2019 | 1.32M | +92.0% |
| 2018 | 685,747 | -84.0% |
| 2017 | 4.29M | +2.2% |
| 2016 | 4.20M | -72.1% |
| 2015 | 15.05M | +84.4% |
| 2014 | 8.16M | +24.0% |
| 2013 | 6.58M | +58.9% |
| 2012 | 4.14M | -84.4% |
| 2011 | 26.58M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 1.73M | +7.1% | +4.9% |
| September 30, 2025 | 1.65M | +23.2% | +0.4% |
| June 30, 2025 | 1.64M | -91.4% | +0.5% |
| March 31, 2025 | 1.63M | +109.4% | +1.1% |
| December 31, 2024 | 1.62M | -88.2% | +20.7% |
| September 30, 2024 | 1.34M | -74.2% | -93.0% |
| June 30, 2024 | 19.00M | +269.6% | +2335.3% |
| March 31, 2024 | 780,371 | -84.2% | -94.3% |
- Sonoma Pharmaceuticals, Inc. showed an increase of +54.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, Sonoma Pharmaceuticals, Inc.’s shares outstanding has declined by 93.9% (from 26.58 million shares to 1.63 million shares).
- The most recent figure is from Sonoma Pharmaceuticals, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: